About ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate
ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate (PubChem CID 135330472) has the molecular formula C36H47N5O4
and a molecular weight of 613.80 g/mol. Its IUPAC name is ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate.
Molecular Properties
| Compound Name | ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate |
| PubChem CID | 135330472 |
| Molecular Formula | C36H47N5O4 |
| Molecular Weight | 613.80 g/mol |
| Exact Mass | 613.36 |
| IUPAC Name | ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate |
| SMILES | CCOC(=O)CC1CCC(C(=O)N(CC2CCC(c3ccc(OC)c(C)n3)CC2)c2cc(-c3cnn(C4CC4)c3)ccn2)CC1 |
| InChI | InChI=1S/C36H47N5O4/c1-4-45-35(42)19-25-5-11-28(12-6-25)36(43)40(34-20-29(17-18-37-34)30-21-38-41(23-30)31-13-14-31)22-26-7-9-27(10-8-26)32-15-16-33(44-3)24(2)39-32/h15-18,20-21,23,25-28,31H,4-14,19,22H2,1-3H3 |
| InChIKey | WLWAUDWDUDBADH-UHFFFAOYSA-N |
| XLogP | 7.06 |
| TPSA | 99.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 613.80 |
| LogP ≤ 5 | 7.06 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate?
The IUPAC name of ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate (CID 135330472) is ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate.
What is the SMILES notation for ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate?
The canonical SMILES for ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate is CCOC(=O)CC1CCC(C(=O)N(CC2CCC(c3ccc(OC)c(C)n3)CC2)c2cc(-c3cnn(C4CC4)c3)ccn2)CC1.
What is the InChIKey of ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate?
The InChIKey is WLWAUDWDUDBADH-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H47N5O4/c1-4-45-35(42)19-25-5-11-28(12-6-25)36(43)40(34-20-29(17-18-37-34)30-21-38-41(23-30)31-13-14-31)22-26-7-9-27(10-8-26)32-15-16-33(44-3)24(2)39-32/h15-18,20-21,23,25-28,31H,4-14,19,22H2,1-3H3.
What are the key properties of ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate?
ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate has a molecular weight of 613.80 g/mol, XLogP of 7.06, 11 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[4-[[4-(1-cyclopropylpyrazol-4-yl)-2-pyridinyl]-[[4-(5-methoxy-6-methyl-2-pyridinyl)cyclohexyl]methyl]carbamoyl]cyclohexyl]acetate is sourced from PubChem (CID 135330472), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).